Clinical Trial Update: Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 18F-AV-1451 in Alzheimer's disease, reporting follow-up scan results from confirmatory cohort (Study 18F-AV-1451-A05).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-AV-1451 (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-24